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PRESIDENTIAL PANEL 
JAMES H. NELSON, JR., M.D., President 
Society of Gynecologic Oncologists, 1981-1982 
This Presidential Panel was conceived by Dr. Leo Lagasse, the Immediate 
Past President of the society. It should be pointed out that Dr. Lagasse is the 
current Director of the Division of Gynecologic Oncology of the American Board 
of Obstetrics and Gynecology. His position as such makes the conception of 
this panel even more strikingly important in .the current scene in this country. 
First, the United States is the first country in the world to identify a subspecialty 
of gynecologic oncology, and I might add amid more than moderate opposition. 
Those early years when I served as one of the original five directors of the 
Division of Gynecologic Oncology of the American Board were turbulent years 
to say the least. I finished my five-year term on the division feeling proud and 
happy in regard to the accomplishments. I truly believed and still believe that 
we had created a very worthwhile, indeed a vital, need in the specialty of 
obstetrics and gynecology. In addition, we had recognized the importance of the 
nonsurgical aspects of the field of obstetrics and gynecology, namely, the other 
two Divisions of the American Board: Fetal and Maternal Medicine and Repro- 
ductive Endocrinology. I personally felt that the formation of subspecialty divisions 
was the savior of our specialty because it offered broad horizons for the graduating 
medical student wrestling with the question of how to use his medical education. 
The developments of the past several years, however, have shaken my feelings 
of triumph but these misgivings have come from areas I would never have 
anticipated. Gynecologic oncologists are leaving academic departments to enter 
private practice with surprising regularity. Is this happening because of economics, 
is this happening because of the nature of the beast who goes into gynecologic 
oncology? Today’s Presidential Panel was constructed toward the objective of 
answering that question, namely, why are gynecologic oncologists leaving academic 
departments. I believe this is a critical question and, therefore, I felt it fitting 
for this society to spend this time in an effort to answer the question. Dr. George 
Morley has been kind enough to take on this task and has searched the minds 
of the membership in an effort to answer the question. 
REPORT OF SURVEY 
GEORGE W. MORLEY, M.D. 
In early 1981, a Task Force3 was appointed by the Executive Council of the 
Society of Gynecologic Oncologists to evaluate the status of gynecologic oncology 
within Departments of Obstetrics and Gynecology in the United States. A ques- 
tionnaire was developed by this Task Force which included such important issues 
as practice profile, hours committed to medicine and to the subspecialty, surgical 
3 Task Force Members: Hervy E. Averette, M.D.; Samuel C. Ballon, M.D.; David L. Barclay, 
M.D.; Richard C. Boronow, M.D.; Leo J. Dunn, MD.; Robert D. Hilgers, M.D.; Leo D. LaGasse, 
M.D.; James N. Nelson, M.D.; C. Paul Morrow, M.D.; Hugh M. Shingleton, M.D.; and George 
W. Morley, M.D., Chairman. 
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procedures one was permitted to perform in the hospital, the value of the gynecologic 
oncologist to the Department of Obstetrics and Gynecology, financial and budgetary 
issues and fringe benefits, and answers to certain assumptions. The questionnaire 
was mailed to all members and candidate members4 of the Society of Gynecologic 
Oncologists. 
The results of the questionnaire were tabulated in the Computer Center at the 
University of Alabama in Birmingham and reported in January of 1982 at the 
13th Annual Meeting of this Society as a Presidential Panel with Dr. James N. 
Nelson, Jr., the presiding officer. Two hundred fifty-eight questionnaires were 
mailed out to the members and candidate members with a 62% (161) return on 
the first mailing. Once the summary of the survey was presented, a discussion 
followed. 
In presenting a summary of the survey, the median age of the members was 
47; the median age of the candidate members was 37. Sixty-two percent of the 
members and sixty-nine percent of the candidate members were either salaried 
or were geographic full-time in a university. Eight percent of the members and 
ten percent of the candidate members were in private practice. Sixteen percent 
of the members and seven percent of the candidate members were chairmen of 
their own departments of obstetrics and gynecology. In departments where the 
responder was not the chairman, forty percent of the chairmen were certified 
subspecialists. When asked why more gynecologic oncologists were not chairmen 
of departments, the responses showed that our subspecialty was too specialized; 
that the patient care and teaching demands were too great to allow for administration 
and research; and that if they did become chairmen, this would lessen their 
contribution to gynecologic oncology and decrease their revenue production. 
Eight percent of those responding left academic medicine during the previous 
five years because of “frustrations with academia and inadequate salaries from 
the university.” 
In an analysis of the time commitment to the profession, both groups reported 
the median number of hours per week devoted to all aspects of medicine at 63 
with 90% of this time being spent in gynecologic oncology. When asked if they 
spent too much time in medicine, the answer was equally divided between “yes” 
and “no.” In addition, 59% (94) of those responding felt that they spend too 
much time in patient care; whereas 5% stated that they needed more time for 
teaching; and 92% needed more time for research. 
One of the most important aspects of the questionnaire analyzed the frequency 
with which the members from both groups were permitted to perform nongy- 
necologic procedures in their hospitals, e.g., procedures involving the gastroin- 
testinal tract or the urinary system. The responses were quite similar in both 
groups. As noted in Table 1, approximately 90% of the responders were “always” 
permitted to perform sigmoidoscopy, diverting colostomy, and closure of colostomy 
on the in-patients when they were indicated. Over 80% were “always” permitted 
to perform bowel resection, bypass anastamosis, surgery for the alleviation of 
4 Members: Full membership in the Society of Gynecologic Oncologists; Candidate Members: 
eligible for certification of special competence, American Board of Obstetrics and Gynecology. 
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TABLE 1 
GASTROINTESTINAL PROCEDURES “ALWAYS” 
PERMITTED To PERFORM IN RESPONDER’S 
HOSPITAL’ 
Candidate Member 
1. Sigmoidoscopy 89% 
2. Diverting colostomy 90% 
3. Closure of colostomy 90% 
4. Bowel resection 86% 
5. Bypass anastamosis 86% 
6. Intestinal obstruction 82% 








’ “Never” was at the 2-4% level! 
intestinal obstruction, and correction of radiation enteritis. The answer “never” 
was at the 2-4% level. Stated in another way, when the question was asked if 
general surgeons do part of the total pelvic exenteration, 85% said “never.” 
In regard to urologic procedures as noted in Table 2, approximately 65% of 
the responders were “always” permitted to perform cystoscopy on their patients 
when indicated; whereas 24% said “never.” Eighty-six and one-half percent 
were permitted to treat ureteral obstruction and eighty-seven percent were allowed 
to perform urinary diversion “most of the time”5 when indicated on their patients. 
Nephrostomies were not considered a part of the gynecologic oncologists’ ar- 
mamentarium. When asked if urologists do purr of the total pelvic exenteration, 
16% said “never.” 
Next, the interpretation of how valuable a gynecologic oncologist is to the 
department of obstetrics and gynecology as a member of this department was 
attempted. Whereas specific figures recorded are available, it must be realized 
that these answers were from gynecologic oncologists and not from other members 
of the department; therefore, they are omitted from the report of this survey. 
A summary of the comments made by gynecologic oncologists, however, showed 
that they were a valuable addition to departments of obstetrics and gynecology. 
The positive comments suggested that the gynecologic oncologist is the primary 
consultant to the department for complex surgery and surgical complications and 
that this individual provides most of the teaching of anatomy and surgical techniques 
to the residents. The negative comments revealed the presence of a significant 
amount of ambivalence among the faculty members and resident-fellow conflicts 
exist because of an apparent decrease in the number of surgical cases for which 
the resident was responsible. However, 75% of the responders stated that the 
fellowship strengthened the residency most of the time. Finally, it is thought 
that other members of the department think there is too much focus of attention 
on gynecologic oncology. It also should be noted that 66% of the gynecologic 
oncologists did not take obstetric night call. 
’ “Most of the time” defined as: 75% of the time or greater. 
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TABLE 2 
UROLOGIC PROCEDURES “ALWAYS” OR “Mosr OF 





Ureteral obstruction 73% 
Urinary diversion 80% 
“Most of the Time”b 
Cystoscopy 74% 
Ureteral obstruction 86% 
Urinary diversion 84% 
’ 24% said “Never.” 








A disclosure of the median wages for both groups from the financial and 
budgetary section of the questionnaire is considered somewhat meaningless and, 
most importantly, inaccurate since all of these figures would have to be “cross- 
referenced” with the fringe benefits, the age of the individual, and the responder’s 
academic rank. Much more meaningful, however, is the observation that 75% 
of the members and 40% of the candidate members were reasonably satisfied 
with their total professional income and most of the responders were satisfied 
with the fringe benefits that were provided for them through their own institution. 
Over 50% thought that the salary of the gynecologic oncologist should be based 
on their generated incomes. 
Given that most people desire a greater income, 60% of the members and 47% 
of the candidate members were satisfied with their current income as it compared 
to the other subspecialists in the department; and 63% of the members and 43% 
of the candidate members were satisfied with their incomes when compared to 
the nonspecialists in the department. Fifty-six percent of the members and seventy 
percent of the candidate members considered themselves overworked and un- 
derpaid; 33% of the members and 57% of the candidate members have considered 
leaving academia for financial reasons. (See Table 3). 
A number of assumptions were addressed by the questionnaire. In assuming 
that obstetrics and gynecology remains a combined specialty, 90% of the responders 
stated that gynecologic oncology should remain a division within the department 
of obstetrics and gynecology; however, it was suggested that the lure of greater 
financial reward will eventually overcome the intellectual reward of academia. 
It is to be noted that according to the results of the questionnaire there will be 
a definite increased exodus of subspecialists from academic medicine into the 
private sector practicing in community hospitals and that some fellows are taking 
gynecologic oncology fellowships to improve their surgical skills with the full 
intention of doing obstetrics and gynecology in the future with a special interest 
in gynecologic oncology-probably in the community hospital. 
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TABLE 3 
Candidate Member 
QUESTION: Are you overworked and underpaid? 
Yes 70% 56% 
No 13% 26% 
No answer 17% 19% 
QUESTION: Have you considered leaving academic 
medicine for financial reasons? 
Yes 57% 33% 
No 24% 51% 
No answer 19% 16% 
Finally, in reporting general observations about the future, a significant number 
of responders replied that there will be a marked decrease in the number of 
patients available for resident training in the universities; that only the better 
fellowship programs in gynecologic oncology will survive; that private gynecologic 
oncologists will teach part-time in the academic institutions; that there will be 
an oversupply of gynecologic oncologists in the near future; that university 
departments will get the “poor pay and indigent” patients; that the residents in 
nonfellowship programs will get the best of both worlds if a gynecologic oncologist 
is on the staff; and that the cancer patient will want continuity of care in their 
community hospital leaving the area only when appropriate care is unavailable 
locally. 
In summary, it appears that the three most important issues are a desire for 
a greater professional income; a need to relieve the frustrations associated with 
academic medicine; and a realization that the patient wants continuity of care 
in the local or nearby community hospital if it is available. 
THE PERSPECTIVE OF A DIVISION CHIEF 
HERVY E. AVERETTE, M.D. 
Thank you, Mr. President, for the privilege of commenting on the survey 
conducted by the Society and so thoroughly analyzed by Dr. Morley. 
At the Fifth Annual Meeting of the Society, in January 1974, the Presidential 
Panel was entitled, “The Role of the Gynecologic Oncologist in the Community 
Hospital, the University Hospital, and the Cancer Center.“ Since at that time 
none of the 82 members in the Society was in private practice, John Mikuta 
discussed liaison with the Community Hospital, John Lewis described the Cancer 
Center Program, and I discussed the University Oncology Program. From my 
presentation on January 8, 1974, I will read what I said at the conclusion of my 
presentation since it seems pertinent in 1982 from the survey that we have heard, 
and it is as follows: 
My last comments regarding the University-based gynecologic oncologists are related to 
the problems, or potential problems, that he must face. 
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First, he must have total support by the Chairman of the Department of Obstetrics and 
Gynecology through delegation of authority to conduct all activities of the Gynecologic 
Oncology Service. The oncologist should be responsible for insuring that treatment protocols 
are strictly adhered to for all cancer patients since there is no place for whimsical decisions 
made by numerous faculty or attending physicians who infrequently treat gynecologic cancer. 
The Department Chairman, also, should support the gynecologic oncologist if any confrontation 
results with other disciplines such as urology, general surgery, or medical oncology. Urologic 
and gastrointesinal surgery as well as chemotherapy related to the overall care of gynecologic 
cancer patient rightfully belong within the area of gynecologic oncology, and any division 
of responsibility inevitably results in poor patient care. Although this problem has diminished 
in most University centers in recent years, I am aware that some chairmen continue to 
offer little support to their oncologists. 
Another potential problem for the gynecologic oncologist is lack of support from hospital 
administration and the ancillary services. Too often administration, nursing service and the 
anesthesia department look upon an admission to the obstetrics and gynecology service as 
just another vaginal hysterectomy or tubal ligation, and little will be required of them for 
the short hospitalization. In contrast, they expect and do provide specialized nursing and 
intensive care for an admission to the cardiovascular or neurosurgical service. All of the 
hospital supportive services must be educated regarding the importance of adequate hospital 
laboratory facilities as well as the necessity for intensive nursing care for the oncology 
patient. The anesthesiologist must be aware that a pelvic exenteration is not just another 
hysterectomy. In our own institution, we demonstrated several years ago that 45% of our 
postoperative deaths from pelvic exenteration probably were preventable. Since that time, 
we have had the necessary supportive care and only one postoperative death. 
Although there are many other important aspects that could be considered for the University 
oncologists, I will summarize what seem to be the major problems that must be solved- 
namely, priorities and proper allocation of his professional effort. By necessity, the University 
oncologist must be involved with graduate education at all levels-students, residents, 
fellows and postgraduate programs. Easily he could spend all of his time in this area. He 
is expected to carry out an active research program, both clinical and laboratory. There is 
no need to emphasize to this group the time one can spend preparing reasearch grant 
proposals with progress reports as well as clinical research protocol reports. Other commitments 
invariably arise for the faculty member in the University Hospital. Not only is he involved 
with the usual activities of the teaching program, he must find time to serve on various 
committees of the University, which can be very time consuming. He is expected to publish 
the results of his investigation as well as present the material at meetings. Although he may 
excel in all other areas listed, unless this obligation is met, his position for advancement 
within the academic ranks will be in jeopardy with the promotions and tenure committee 
of the University. 
Lastly, I mention patient care, which certainly is not the least important activity of the 
oncologist. Although he may have an able staff of assistants, he must devote personal 
attention to the patient, the family, and referring physicians. The last area will be time 
consuming for the oncologist in the community hospital, the Cancer Center or the University 
Program, The first three categories may be less demanding in a setting other than the 
University Hospital. 
In summary, I have attempted to describe the development of a single University Gynecologic 
Oncology Program including commitments the oncologist has as well as problems or potential 
problems that he must manage. I will end with a personal comment. I find that the University 
oncologist who usually is compulsive and demanding, has many things to do, most of which 
are not easy and usually require a lot of time. Under such circumstances, frustration often 
results, which probably is the greatest problem he must confront and manage properly. 
That concludes my presentation in January 1974. It is clear from the data 
summarized by Dr. Morley that problems and potential problems that I referred 
to in 1974 exist now. Of those who have entered private practice in the past five 
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years, many left because of “academic frustrations” rather than salary-a figure 
that surprised me. Failure for complete support from the chairman was of primary 
importance and I suppose part of this related to surgical privileges. A figure of 
importance is that approximately 20% of members do not do their own gas- 
trointesinal surgery. Clearly, these individuals are working under adverse cir- 
cumstances while trying to offer total care to the patient with gynecologic cancer. 
The last figure that was revealed in the survey on which I will comment is 
the response that 88% of members and 69% of candidate members believe there 
will be an increase in the move from academic to private practice. This I expected 
since most medical schools have recruited oncologists, and, in private practice, 
many of the responsibilities of academia are relieved. I think it is appropriate 
that gynecologic oncologists move into the community hosipitals to enhance care 
for more women with gynecologic cancer. Since this is an inevitable trend, I 
hope that in 1982 the younger people in the audience who plan such a move do 
so with care. In February 1970, shortly after this society had its first organizational 
meeting at Key Biscayne in January 1969, we were referred to, at a national 
meeting, as a “splinter group” called the SOGS, or the “Society of Oncologic 
Gynecologists.” Well, the SOGS formed, and I think successfully, into a sound 
organization that has accomplished much to centralize and standardize therapy 
for women with cancer. The most threatening problem I see to our new discipline 
in 1982 is-to paraphrase from the 1970 reference-the emergence of a new breed 
that I call the POGS, or the “Peripatetic Oncologic Gynecologists.” Although 
they are small in number-in the past few months, I have heard of their proliferation 
on the West Coast, Midwest, and East Coast-these are the few individuals 
who, rather than develop a strong, well-supervised oncology program in one 
larger medical center, yield to the call of the private obstetrician to come to his 
hospital to “scrub in” and do the cancer operation so that he may assist-and 
I might add-collect the surgical assistant’s fee. Postoperatively, the patient is 
left in the hands of the generalist who often is ill equipped to care for the seriously 
ill patient. Indeed, adjunctive therapy is often left to the radiologist or medical 
oncologist in the small hospital, often because the gynecologic oncologist does 
not have those privileges. This decentralization of well-supervised patient care 
is, to me, clearly the major threat to advancement of our young discipline. My 
final comment-for those young people who plan a career in the private sector- 
develop your own oncology referral program in a medical center and hope that 
the era of the POGS will be short lived. 
THE PERSPECTIVE OF ONE WHO LEFT ACADEMIA 
TO ENTER PRIVATE PRACTICE 
RICHARD C. BORONOW, M.D. 
As one who spent twelve years in academic medicine and then the last five 
years in full-time private practice, I would like to comment on the problem of 
attrition from academia to the private sector and some of the reasons, given and 
otherwise, for this attrition. 
As this questionnaire was evolved, there was the feeling among many that all 
was not well with the gynecologic oncologist in his Department of Obstetrics 
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and Gynecology; that there was a tendency toward moving from academia to 
the private sector; and that this attrition would have an unfavorable impact on 
University communities in terms of clinical investigation, research, and teaching. 
Clearly there is some truth to each of these concerns, and, of course, these 
concerns are not unique to gynecologic oncology. In his Del Regato Lectureship 
a few years ago, the distinguished Gilbert Fletcher lamented over the proliferation 
of community radiotherapy “centers,” suggesting that they were sapping material 
from the larger more sophisticated centers where more clinical and investigative 
work is going on [l]. In fact, Leighton Cluff in the January 8, 1982 issue of 
Journal of the American Medical Association discusses this problem for all of 
medicine in a penetrating report from the Robert Wood Johnson Foundation [2]. 
This is must reading for all. We must first, however, place this attrition in 
perspective. 
The questionnaire discloses that in the last five years 12.9% of the members 
and 12.1% of the candidates moved from full-time academia to either part-time 
or full-time private practice. In spite of some attrition, the survey reflects that 
81% of members and 93% of candidates remain in academic medicine, either 
full-time, geographic full-time, or on a cancer institute staff. The converse is 
that only 19% of members and only 7% of candidates are in nonacademic settings. 
To compare this with other medical fields, it is of interest to inspect data from 
the AMA Masterfile for Selected Specialties using “office based practice” 
as a reasonable definition of the non-academic-based private practioner. While 
comparisons may not be entirely precise, they are close and our 19 and 7% 
“private practice” groups seem almost insignificant compared to the 69%, for 
example, in therapeutic radiology and 94% in the subspecialty of colorectal 
surgery. So the fear of attrition to private practice may not be as great as some 
would believe. 
The clustering of gynecologic oncologists in medical school settings will inevitable 
change somewhat with time as has, for example, the distribution of cardiovascular 
surgeons and therapeutic radiologists. It seems appropriate that most be in ed- 
ucational settings, however, as the academic environment remains in the forefront 
of new information, clinical trials, and research. Nevertheless, high-quality work 
can and is maintained in the private practice setting. And where the patient 
volume and physical support and professional staff justify it, this seems entirely 
appropriate in the context of the scenario of American medicine-lest we are 
socialists. A real problem that I can foresee is the men or women who, despite 
their training, are able in practice to generate only a small to moderate cancer 
practice and who must, by economic necessity, do the spectrum of gynecology 
and obstetrics to make a living. I feel we must be essentially in full-time oncologic 
practice to remain current, irrespective of our practice setting. I caution, therefore, 
that part-time gynecologic oncologists, like part-time cardiac surgeons, may well 
lose their competency. 
It is my personal view that entry into the private sector for those who may 
wish to pursue this course is best delayed for at least several years for our 
subspecialists for several reasons: (1) the requirement for advanced certification 
mandates an additional two years of clinical experience in an entirely suitable 
setting; (2) trainees can pay their dues by contributing much in terms of academic 
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teaching responsibilities, participating in clinical studies, cooperatives, and the 
like, and preparing formal and informal talks and presentations, manuscripts, 
and other forms of scientific scholarship; (3) additional clinical experience inevitably 
matures and seasons the neophyte clinician [3]. The words of Hemingway seem 
appropriate here: “There are some things that cannot be learned quickly. And 
time-which is all that we have-must be paid heavily for their acquiring.” 
Some, however, are impatient. They have that right. 
A large segment of the questionnaire was dedicated to economic considerations. 
The mean, total, professional income of responding members was analyzed. Add 
to this the sizable package of fringe benefits most received, such as malpractice 
insurance, professional travel, dues, and subscriptions, not to mention secretaries, 
nurses, and space, etc., and the overall package is quite sizable. All of this is 
out of our own pocket in private practice. 
When asked how much more income they thought they should have, the most 
common answer for both members and candidates was 50% more. Private practice 
overhead expenses are large and probably not fully appreciated by the academician. 
Yet 33% of the members and 57% of the candidates have considered leaving 
academic medicine for financial reasons. Over 50% of both groups feel they are 
“overworked and underpaid” and many feel their workload is much heavier 
than that of most of the academic department. Well, really, isn’t that sad! Do 
you know how many who do not feel that way? Have we not heard of Mr. and 
Mrs. Average American Worker, the AFL-CIO, the UAW or PATCO! Really, 
these figures only admit that we’re better off than the average American. 
Ultimately, the unspoken reasons came from within. It seems to me that our 
group comprises “achievers.” Our temperaments, our personalitites, our energies, 
our needs-indeed our agitation about our work-are all a reflection of our inner 
self, and we do not generally know that inner self as well as we might think we 
do. Most of us are “workaholics.” Either full blown or borderline! This sydrome 
is rampant among what 20th-century America refers to as “the successful.” 
When we can come face to face with the fact that we live to work, rather than 
work to live-we are workaholics. 
Achievement is not an altogether pure virtue. In fact, this mixed blessing is 
usually the product of very intense inner drives and needs. We are generous 
with ourselves by calling this “motivation.” But satisfying our deepest needs 
becomes the “monkey on our back” that results in workaholism. This intensity 
is fierce; this drive is highly stressful. Workaholics are particularly subject to 
“life’s deadly D’s: dissatisfaction, depression, divorce, disease, and death.” This 
intensity can be destructive. 
So regarding the attrition to private practice, I see three special challenges 
that relate to some of the frustrations of some of our leadership. 
1. The first challenge is to the universities, the deans, the department chairmen, 
who must reevaluate traditional concepts of fixed or semifixed salaries for the 
scientific scholarship of their teaching physicians. Many schools and departments 
have evolved fair, even generous formulas to reward productivity and effort, 
thereby retaining desirable faculty. This approach has always seemed fair and 
sensible to me. While fair and sensible, it is also extemely prudent in days of 
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dwindling soft Federal money. Deans and chairmen must give the formula approach 
a more open-minded “second look.” 
2. The second challenge is to town and gown. There exists a clear mandate 
for cooperation among medical schools, clinical faculty and community physicians 
as community “medical centers” achieve more and more diverse specialized 
competence. 
3. The third challenge is to ourselves as individuals. We must acknowledge 
as best we can that our work is part, and hopefully not all, that is required for 
the fulfillment of our own needs. 
Our education and training experiences imbue us with an idea of the essentials 
for quality medical practice which are (1) knowledgeability, (2) availability, and 
(3) affability. These three were enunciated to me during my residency by Edward 
F. Scanlon, M.D. [personal communication], recent Past President of the American 
Cancer Society and also a Past President of the Society of Surgical Oncology. 
In the academic setting, there is the stimulus of clinical investigation and the 
challenge to excellence from peers and trainees. We like to think of ourselves 
as students of the diseases we treat not just “treaters.” This intellectual stimulation 
and gratification will always be the most important part of the reward equation 
in academic medicine, even with improvement in economic benefits, 
The practicality of the “real world,” however, is very clear. Scanlon reminds 
us that the “essentials” referred to above are not so subtly altered. The essentials 
for private practice are (1) affability, (2) availability, and (3) knowledgeability! 
The appreciation, even worshipful adoration, by patients for their physicians has 
long been an extremely important part of the reward equation in private practice. 
It has been said that “physicians take care of their patients.” It may be more 
accurate to say that “patients take care of their physicians.” Virtually anyone 
and everyone can make a good living in private practice. But I can tell you that 
“keeping current” is more difficult. And peer review is far, far less evident. 
Each sector marches to different drummers, but we are all in the same parade. 
In the final analysis, each must look at our own work and assess its role in the 
fulfillment of the spectrum of our own needs. 
Regarding work in academia, we must thoughtfully evaluate-in the context 
of these needs-the price to stay in and the price to leave. For each person, it 
becomes a highly individual appraisal. Finally, as we better appreciate the “work- 
aholic” in ourselves, we must strive for modification, so that we can reach the 
goal of “working to live” rather than “living to work.” We must recognize it 
and modify this before it is too late. 
THE PERSPECTIVE OF A DEPARTMENTAL CHAIRMAN 
LEO J. DUNN, M.D. 
The first comment I would like to make is to in regard to the validity of the 
questionnaire. You must recognize that this questionnaire was given only to 
gynecologic oncologists and therefore the response cannot be regarded as being 
specific to that group. It is entirely possible that the same response would be 
received from other individuals in academic medicine. Furthermore, some of the 
question items might have had different responses if asked of other individuals. 
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Specifically, those items regarding how well accepted or regarded the gynecologic 
oncologist is by other groups may very well have produced different information 
if those groups had been asked. Finally, some questions have predictable responses. 
As an example, I would ask, when you heard someone say that they earned too 
much money or even enough money? How often (even outside of gynecologic 
oncology) does one hear that one is overworked? Therefore, positive responses 
to these questions are virtually predictable and this should be realized in analyzing 
the data. 
I have broken down my comments regarding specific items reported on the 
questionnaire into several segments and would like to present them under various 
categories. 
Old Truths Rediscovered 
1. “Private practice is more lucrative than academic positions.” This fact has 
been well known in the past, remains true at the present time, and it seems that 
it will continue to be so. Therefore, the document has not uncovered something 
unique regarding Gynecologic Oncologists. 
2. “Private hospitals are easier to work in.” This also has always been true. 
It is unfortunate that private hospitals are more physician and patient oriented 
and that university hospitals tend to lose their competitive edge. However, this 
also is not a new discovery uncovered by this document. 
3. “Private hospitals are more attractive to patients.” This is also true for the 
reasons stated above. 
4. “Doctors work long hours.” This has been traditionally so. It has also been 
demonstrated that physicians in academic medicine often work longer hours than 
physicians in practice situations. How they spend that time is, of course, frequently 
very different. 
5. “Far off fields look greener.” This is one aspect of human nature that leads 
everyone to believe that the other fellow has it better. It is not restricted to 
persons in academic medicine but exists in private practice and in other professions 
or occupations. 
6. What are the problems as the oncologists see them? The gynecologic oncologists 
primarily seem to be concerned with the belief that their salaries are not com- 
mensurate with their output. Since their output is largely related to patient care 
situations they feel that personal income should be closely linked to productivity 
from their practices in the academic setting. From the standpoint of a department 
chairman you must recognize that creating this type of direct linkage of salary 
to private practice productivity absolutely discourages efforts in teaching and 
research. The individual who would spend any substantial period of time in 
teaching or research would be clearly penalized financially for doing so. One 
should also note that this questionnaire indicates that the gynecologic oncologist 
is frustrated because of lack of time for teaching and research. This complaint 
then goes in the opposite direction of the issue of salaries. From an administrative 
standpoint it is illogical to complain about both of these issues since solving one 
would worsen the other. 
Each academic faculty member must recognize the financial problems faced 
by the department as a whole. Close linkage of salaries to private practice 
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productivity would create a disadvantage in recruiting new faculty members, 
since their private practice productivity is almost zero for the first six months 
and very little for the second six months. Therefore, new faculty need to be 
supplemented and these dollars must come from somewhere. One must also 
realize that the practice income for the aging physician generally declines whereas 
the academician continues to increase his or her salary to the time of retirement. 
These dollars must be made up from somewhere as well. Furthermore, many 
faculty look only at their gross income and forget that, considering the usual 
costs of practice, the net income is less than half. In addition, fringe benefits 
often come from these practice dollars and must be included when one is calculating 
overall income. This includes such items as travel, memberships to academic 
societies. 
Gynecologic oncologists have also complained that their personal lives become 
restricted because of the demands of their work which does not allow them to 
“paint their own homes,” “cut their own grass,” etc. This is a real problem 
because we have not as yet reached the number of certified gynecologic oncologists 
that was predicted as our need. Therefore those who are practicing this subspecialty 
are still in the position of handling a very large workload. However, you must 
recognize there is also a personality issue involved here. Even in this survey 
the gynecologic oncologists recognize their compulsive natures. You are sitting 
in a room with two hundred obsessive/compulsives who, if given the opportunity 
to have free time, would find some work with which to fill it. This is not 
necessarily a negative trait as compulsiveness is a desirable trait in physicians, 
in my opinion. 
The Problems as Departmental Chairmen See Them 
These comments come from talking to a few departmental chairmen who have 
dealt with gynecologic oncologists within their departments. One complaint is 
that the oncologist does not take an active interest in the affairs of the department. 
They stay somewhat isolated from the remainder of the department. This criticism 
may have real validity. This survey does indicate that the gynecologic oncologist 
does not regularly participate in departmental grand rounds, as an example. 
Furthermore, the long working hours of present day gynecologic oncologists 
probably make it difficult for them to participate in committees and other similar 
activities within the academic setting. One must recognize that these issues can 
give the impression of a lack of interest or desire to associate with the department 
as a whole. 
There has been expressed the reluctance of the oncologist to share in obstetric 
call schedules. This varies a good deal with the size of the department and the 
method of funding within the department. One must recognize that in small 
departments there is the problem of manpower to cover the labor and delivery 
unit over nights and weekends. There are also a number of departments who 
depend upon supervision of such insured patients as a major part of faculty 
funding. These situations are not uniform and they vary a good deal from one 
center to another. I would expect that these problems will lessen as departments 
grow in size and there will be concern as to how current an oncologist will be 
in obstetric judgment. 
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The departmental chairmen also feel the oncologist can have an unreasonable 
expectation regarding their income. I point out that it is not possible to be 
functioning in an academic setting and to be paid as a private practitioner. This 
problem gets close to a real issue since gynecologists do spend their time in 
patient care much as a practitioner does. Unless they develop time and skills 
that bring them the rewards of academic life, there will continue to be this type 
of dissatisfaction. 
It is stated that the oncologist’s research effort is small. This appears to be 
very true and almost uniform. Not only is the research effort small but it is 
considered to be at a very primitive level. Much of the “clinical research” still 
amounts to statistical studies of how many cases had a five-year cure and how 
many complications occurred, etc. This type of research is viewed as being at 
a much lower level than that being accomplished by other specialists within the 
same department. I believe there is some truth to this and I think that this society 
and the Division of Gynecologic Oncology must be acutely aware of the fact 
that we are only training practitioners in gynecologic oncology as research training 
has been largely neglected. 
Why Is There Unrest? 
I believe that the following are reasons for the unrest among gynecologic 
oncologists. First, these individuals find themselves being a desirable commodity 
at the present time. Therefore, they are presented with a number of options and 
this means making a decision. Since the options continue, the individual is 
constantly presented with the inducement of change to something more attractive. 
This leads to a certain amount of unrest. There also has been implied some 
concern about gynecologic oncologists leaving academic medicine and entering 
private practice. I think we must realize that there was never any requirement 
that the graduates of fellowships for special competence had a requirement to 
devote their careers to academic medicine. There is no prohibition against entering 
private practice in any of these areas. Considering the fact that fewer than 10% 
of the graduates of residencies in general obstetrics and gynecology enter academic 
medicine, we should be impressed by the fact that fewer than 10% of the graduates 
of fellowships in gynecologic oncology enter private practice! The trends are 
almost exactly opposite. Therefore, if this trend continues, the academicians of 
the future disproportionately will come from fellowships and have a great influence 
on the future of the specialty. In a sense we should have less concern about the 
gynecologic oncologist who enters private practice than our specialty should 
about the influence on our future by gynecologic oncologists who stay in academic 
medicine. 
The next item of unrest is the income differential between academic medicine 
and private practice. This differential, as I have previously stated, has always 
existed. The concern has been further expressed that this differential will cause 
a sudden and complete abandonment of academic posts by gynecologic oncologists, 
all of whom will enter private practice. I seriously doubt that this will happen. 
Although there is significant income differential between academic and private 
practice income within gynecologic oncology, we have to recognize that this 
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differential has always existed in urology, orthopedics, and cardiac surgery. It 
also currently exists in’reproductive endocrinology for those individuals who do 
microsurgery. Therefore, gynecologic oncology is not unique in this regard, and 
since these other specialties have continued to attract academicians, I see no 
reason why the outcome will be any different for gynecologic oncology. 
There is also a generation gap that exists between the young graduates of 
training programs and those in the grandfather category. I think we see a difference 
in the expectations and goals of our medical students and residents form those 
of us who graduated some long time ago. Their experiences are very different 
from ours and therefore they seem to have differences in their philosophy. 
There is a very definite financial crunch within academic departments at the 
present time. There is a greater dependence upon practice dollars to support 
these departments. This is particularly true of obstetrics and gynecology, which 
is trying to increase its academic strength at a time when there are declining 
federal dollars. 
There is the reality of workload in gynecologic oncology, as I previously 
mentioned. There are not enough gynecologic oncologists to fill all the needs at 
the present time, but of course one anticipates that this is a self-limited problem. 
There is a real problem in the oncologist as an academician. First, I think an 
oncologist is primarily trained to be a practitioner. Second, I think there is a 
significant educational gap that exists for a resident who enters a fellowship in 
gynecologic oncology. The informational and skills gap that exists between the 
graduate of residency and what is needed for the fellow in reproductive endo- 
crinology and the fellow in maternal-fetal medicine is far less than that which 
exists for gynecologic oncology. Therefore, much of the time in a fellowship in 
gynecologic oncology is taken up with filling this educational gap. This in part 
explains the lack of research training in gynecologic oncology fellowships. One 
must recognize the degree of commitment that exists in the other two subspecialties 
toward research. In some programs, a full 50% of the time of training is spent 
in laboratory research. In most oncology fellowships, very little if any time is 
actually spent in learning research tools. This is an issue about which this Society 
and the Division of Gynecologic Oncology should have a special concern. Unless 
something is done, the excellent growth that gynecologic oncology has had in 
this country will plateau and the other subspecialties will clearly exceed it in 
achievement. New information and new discoveries in gynecologic oncology 
should be the responsibility of the certified gynecologic oncologists and should 
not be left to the scientists in other disciplines. Clearly the gynecologic oncologist 
will be an unhappy academician if he or she has never been trained in academic 
pursuits. 
Finally, the question has been raised as to why gynecologic oncologists are 
not more frequently sought after as chairmen. They are not overlooked as far 
as chairmanships are concerned and the claim is not true. However, I think there 
is some problem since there has become a practice of appointing pediatricians 
as chairmen of search committees for departments of obstetrics and gynecology. 
These individuals will favor obstetricians and perinatologists in their searches 
and may have an undue influence on the future of our specialty. I think this 
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should be pointed out to deans who probably make these repetitive appointments 
inadvertantly . 
What Are the Prospects for the Future? 
I believe the following things will be seen in the future. The uniqueness of 
the gynecologic onocologist will fade as supply-and-demand ratios change. We 
will produce enough gynecologic oncologists to fill the need. Oncologists will 
enter private practice and will compete with medical centers as have other 
practitioners before. I believe both groups will survive. The oncologists will not 
split off from obstetrics and gynecology. Were this to happen, it would be a 
group of 300 individuals trying to make their way in the morass of federal 
legislation and other political changes as compared to over 20,000 practitioners 
of obstetrics and gynecology. It is clearly to our advantage to remain with the 
parent specialty. 
In regard to the academic oncologists, I believe they will (a) become more 
specialized, (b) become more research oriented, (c) spend less of their time in 
clinical work, and (d) still complain. 
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